MoneyWorks4Me

IND-Swift Laboratories informs about scheme of arrangement

04 Jan 2025 Evaluate
With reference to earlier disclosure dated 18th May, 2024 regarding the proposed Scheme of Arrangement for Amalgamation of Ind Swift (Transferor Company) with Ind Swift Laboratories (Transferee Company) (Scheme), IND-Swift Laboratories has informed that, pursuant to the joint First Motion Application filed by the Company and Ind Swift with the Hon’ble NCLT Chandigarh Bench, the Hon’ble NCLT has passed an order dated January 3, 2025. In the said order NCLT has issued directions to the Company for dispensation of the meeting of secured creditors and convening the meeting of its equity shareholders and unsecured creditors, for the purpose of considering and, if thought fit, approving with or without modification(s) the arrangement embodied in the Scheme. The dates of the aforementioned meetings along with the copy of the notices of the same shall be submitted by the Company in due course with the stock exchange(s). The Copy of the order is available on the website of the Hon’ble National Company Law Tribunal.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..